Company Filing History:
Years Active: 2018-2022
Title: Cesare Federico: Innovator in Alzheimer's Treatment
Introduction
Cesare Federico is a notable inventor based in Perugia, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for Alzheimer's disease. With a total of 2 patents, his work is recognized for its potential impact on medical science.
Latest Patents
Federico's latest patents focus on S1P3 antagonists. The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, specifically for the treatment of Alzheimer's disease. This innovative approach highlights his commitment to addressing critical health challenges.
Career Highlights
Cesare Federico is currently associated with Teva Pharmaceutical Industries Limited, where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key player in the quest for effective treatments for neurodegenerative diseases.
Collaborations
Throughout his career, Federico has collaborated with talented individuals such as Chiara Caramelli and Emanuele Gabellieri. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Cesare Federico's contributions to the field of pharmaceuticals, particularly in the development of S1P3 antagonists for Alzheimer's treatment, underscore his role as a significant inventor. His ongoing work promises to make a lasting impact on medical science and patient care.